B. Villeret

发表

Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity.

J. Sallenave, B. Crestani, I. García-Verdugo, 2019, Biomaterials.

The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine

M. Le Bert, V. Lagente, F. Rassendren, 2015, Cell Death and Disease.

Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis

S. Fuchs, S. Berrih-Aknin, M. C. Souroujon, 2016, Oncotarget.

B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis.

B. Ryffel, P. Schneider, J. Gottenberg, 2015, Journal of autoimmunity.

Pseudomonas aeruginosa LasB Subverts Alveolar Macrophage Activity by Interfering With Bacterial Killing Through Downregulation of Innate Immune Defense, Reactive Oxygen Species Generation, and Complement Activation

J. Sirard, J. Sallenave, R. Voulhoux, 2018, Front. Immunol..

Blockade of IL-1R signaling diminishes Paneth cell depletion and Toxoplasma gondii induced ileitis in mice.

S. Zheng, B. Ryffel, T. Sécher, 2013, American journal of clinical and experimental immunology.

Discordance in cathepsin B and cystatin C expressions in bronchoalveolar fluids between murine bleomycin-induced fibrosis and human idiopathic fibrosis

T. Reinheckel, S. Marchand-Adam, I. Couillin, 2016, Respiratory Research.

Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis

L. Touqui, J. Sallenave, X. Nassif, 2019, Scientific Reports.

Pseudomonas Aeruginosa Lung Infection Subverts Lymphocytic Responses through IL-23 and IL-22 Post-Transcriptional Regulation

J. Sallenave, J. Kolls, B. Villeret, 2022, International journal of molecular sciences.

Silver Nanoparticles Impair Retinoic Acid-Inducible Gene I-Mediated Mitochondrial Antiviral Immunity by Blocking the Autophagic Flux in Lung Epithelial Cells.

J. Aerts, J. Sallenave, B. Solhonne, 2018, ACS nano.

IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections

J. Sallenave, B. Villeret, I. Garcia-Verdugo, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

Use of IL-6-elafin genetically modified regulatory macrophages as an immunotherapeutic against acute bacterial infection in the lung

J. Sallenave, J. Sallenave, B. Villeret, 2020, bioRxiv.

ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation

B. Ryffel, M. Le Bert, F. Rassendren, 2012, Cell Death and Disease.

Use of Toll-Like Receptor Agonists to Induce Ectopic Lymphoid Structures in Myasthenia Gravis Mouse Models

S. Berrih-Aknin, R. Le Panse, M. Robinet, 2017, Front. Immunol..

Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator–IL-6–antimicrobial–repair pathway

A. Cazes, J. Sallenave, I. Sermet-Gaudelus, 2017, Thorax.

Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin Production and Tissue Resilience

A. Cazes, J. Sallenave, B. Solhonne, 2020, Frontiers in Immunology.

Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis

S. Fuchs, S. Berrih-Aknin, I. Shachar, 2016, Oncotarget.